EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Molecular determinants of state-dependent block of voltage-gated sodium channels by pilsicainide



Molecular determinants of state-dependent block of voltage-gated sodium channels by pilsicainide



British Journal of Pharmacology 160(6): 1521-1533



Pilsicainide, an anti-arrhythmic drug used in Japan, is described as a pure sodium channel blocker. We examined the mechanisms by which it is able to block open channels, because these properties may be especially useful to reduce hyperexcitability in pathologies characterized by abnormal sodium channel opening. The effects of pilsicainide on various heterologously expressed human sodium channel subtypes and mutants were investigated using the patch clamp technique. Pilsicainide exhibited tonic and use-dependent effects comparable to those of mexiletine and flecainide on hNav1.4 channels. These use-dependent effects were abolished in the mutations F1586C and Y1593C within segment 6 of domain IV, suggesting that the interaction of pilsicainide with these residues is critical for its local anaesthetic action. Its affinity constants for closed channels (K(R)) and channels inactivated from the closed state (K(I)) were high, suggesting that its use-dependent block (UDB) requires the channel to be open for it to reach a high-affinity blocking site. Accordingly, basic pH, which slightly increased the proportion of neutral drug, dramatically decreased K(R) and K(I) values. Effects of pilsicainide were similar on skeletal muscle hNav1.4, brain hNav1.1 and heart hNav1.5 channels. The myotonic R1448C and G1306E hNav1.4 mutants were more and less sensitive to pilsicainide, respectively, due to mutation-induced gating modifications. Although therapeutic concentrations of pilsicainide may have little effect on resting and closed-state inactivated channels, it induces a strong UDB due to channel opening, rendering the drug ideally suited for inhibition of high-frequency action potential firing.

(PDF emailed within 0-6 h: $19.90)

Accession: 054439089

Download citation: RISBibTeXText

PMID: 20590641

DOI: 10.1111/j.1476-5381.2010.00816.x



Related references

State - dependent block of voltage - gated sodium channels by 4 - phenoxyphenylpyrazoles. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 579 6, 2003

State-dependent block of voltage-gated sodium channels by the casein-kinase 1 inhibitor IC261. Investigational New Drugs 35(3): 277-289, 2017

State-dependent block of rat brain type IIA voltage-gated sodium channels by phenoxyphenyl pyridines. Biophysical Journal 86(1): 117a, January, 2004

Molecular dissection of lubeluzole use-dependent block of voltage-gated sodium channels discloses new therapeutic potentials. Molecular Pharmacology 83(2): 406-415, 2013

Molecular determinants of voltage-gated sodium channels ubiquitination. Biophysical Journal 86(1): 168a, January, 2004

Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels. Proceedings of the National Academy of Sciences of the United States of America 93(17): 9270-9275, 1996

Molecular determinants of prokaryotic voltage-gated sodium channels for recognition of local anesthetics. Febs Journal 283(15): 2881-2895, 2016

Molecular determinants of beta1 subunit-induced gating modulation in voltage-gated sodium channels. Circulation 94(8 SUPPL ): I109, 1996

State-Dependent Modification of Voltage-Gated Sodium Channels by Pyrethroids. Pesticide Biochemistry and Physiology 97(2): 78-86, 2010

Molecular determinants for the subtype specificity of μ-conotoxin SIIIA targeting neuronal voltage-gated sodium channels. Neuropharmacology 61(1-2): 105-111, 2012

Molecular determinants for sodium-dependent activation of G protein-gated K+ channels. Journal of Biological Chemistry 274(13): 8639-8648, 1999

State-dependent block of voltage-gated Na+ channels by amitriptyline via the local anesthetic receptor and its implication for neuropathic pain. Pain 110(1-2): 166-174, 2004

Molecular determinants of conduction and selectivity in voltage-dependent sodium channels. Journal of Physiology (Cambridge) (523P): 2S, 2000

Binding of the anticonvulsant drug lamotrigine and the neurotoxin batrachotoxin to voltage-gated sodium channels induces conformational changes associated with block and steady-state activation. Journal of Biological Chemistry 278(12): 10675-10682, 2002

Role of the local anesthetic receptor in the state-dependent inhibition of voltage-gated sodium channels by the insecticide metaflumizone. Molecular Pharmacology 81(3): 366-374, 2012